CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced the appointment of Charles Fuchs, M.D., M.P.H., to its Board of Directors.

Berlin Police have outlined the details of a deadly assault after a white delivery vehicle ploughed into crowds near a Pride ...

The Ghana Tertiary Education Commission (GTEC) has instructed all universities across the country to immediately discontinue ...

Cigna Healthcare®, the health benefits division of The Cigna Group (NYSE: CI), is significantly expanding its personalized care management programs through AI-enabled capabilities and predictive ...

A Riverbank family says they've spent the last seven months without running water after flooding they believe was caused by a ...

Employees, former patients and lawmakers are calling conditions at the Solnit South youth psychiatric facility in Middletown ...

Controversial Nigerian content creator DJ Chicken has been released from Kirikiri Correctional Centre after meeting his bail ...